Perifosine overcome MEK inhibitor resistance in PIK3CA-mutated colorectal carcinoma

被引：0
|
作者：
Yamamoto, Yuuta [1 ]
Tsubaki, Masanobu [1 ]
Takeda, Tomoya [1 ]
Matsuda, Takuya [1 ]
Kimura, Akihiro [1 ]
Nishida, Shozo [1 ]
机构：
[1] Kindai Univ, Dept Pharmacotherapy, Fac Pharm, Higashiosaka, Osaka, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P16-1-5
引用
收藏
页码：1050 / 1050
页数：1
相关论文
共 50 条
  • [41] In vitro anticancer effects of alpelisib against PIK3CA-mutated canine hemangiosarcoma cell lines
    Maeda, Marika
    Ochiai, Kazuhiko
    Michishita, Masaki
    Morimatsu, Masami
    Sakai, Hiroki
    Kinoshita, Nayuta
    Sakaue, Motoharu
    Onozawa, Eri
    Azakami, Daigo
    Yamamoto, Masami
    Ishioka, Katsumi
    Sadahira, Takuya
    Watanabe, Masami
    Tanaka, Yoshikazu
    ONCOLOGY REPORTS, 2022, 47 (04)
  • [42] BYL719 (ALPELISIB) FOR THE TREATMENT OF PIK3CA-MUTATED, RECURRENT/ADVANCED CERVICAL CANCER
    Bogani, G.
    Bini, M.
    Ronzulli, D.
    Raspagliesi, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A12 - A12
  • [43] BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
    Bogani, Giorgio
    Chiappa, Valentina
    Bini, Marta
    Ronzulli, Dominique
    Indini, Alice
    Conca, Elena
    Raspagliesi, Francesco
    TUMORI JOURNAL, 2023, 109 (02): : 244 - 248
  • [44] PI3Kα-specific inhibitor BYL-719 synergizes with cisplatin in vitro in PIK3CA-mutated ovarian cancer cells
    Thibault, Benoit
    Thole, Adrien
    D'Angelo, Romina
    Basset, Celine
    Guillermet-Guibert, Julie
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [45] Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
    Chang, Dwan-Ying
    Ma, Wei-Li
    Lu, Yen-Shen
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 193 - 207
  • [46] BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
    Bogani, G.
    Indini, A.
    Bini, M.
    Raspagliesi, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S754 - S754
  • [47] Exceptional Response to Copanlisib in a Heavily Pretreated Patient With PIK3CA-Mutated Metastatic Breast Cancer
    Spathas, Nikolaos
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Oikonomopoulos, Nikolaos
    Psyrri, Amanda
    JCO PRECISION ONCOLOGY, 2020, 4 : 335 - 340
  • [48] XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
    Ehrenschwender, M.
    Bittner, S.
    Seibold, K.
    Wajant, H.
    CELL DEATH & DISEASE, 2014, 5 : e1570 - e1570
  • [49] The Genomic Environment of BRAF Mutated and BRAF/PIK3CA Double Mutated Colorectal Cancers
    Voutsadakis, Ioannis A.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [50] XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
    M Ehrenschwender
    S Bittner
    K Seibold
    H Wajant
    Cell Death & Disease, 2014, 5 : e1570 - e1570
12345